Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Essay
  • Published:

“It can't be done”

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: R. Y. Calne, The Liver Transplant Patient and The Tribute to the Compassion and Skill of the Intensive Care Nurse.
Figure 2: R. Y. Calne, Tribute to the Organ Donor—The Real Hero of Transplantation, 2000.


  1. Billingham, R.E., Brent, L. & Medawar, P.B. Actively acquired tolerance of foreign cells. Nature 172, 603–606 (1953).

    Article  CAS  PubMed  Google Scholar 

  2. Murray, J.E., Merrill, J.P. & Harrison, J.H. Renal homotransplantation in identical twins. Surg. Forum 6, 432–436 (1955).

    Google Scholar 

  3. Calne, R.Y. The rejection of renal homografts. Inhibition in dogs by using 6-mercaptopurine. Lancet 275, 417–418 (1960).

    Article  Google Scholar 

  4. Calne, R.Y. Inhibition of the rejection of renal homografts in dogs by purine analogues. Transplant. Bull. 28, 65–81 (1961).

    Article  CAS  Google Scholar 

  5. Starzl, T.E. et al. Homotransplantation of the liver in humans. Surg. Gynecol. Obstet. 117, 659–676 (1963).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Calne, R.Y. et al. Induction of immunological tolerance by porcine liver allografts. Nature 223, 472–476 (1969).

    Article  CAS  PubMed  Google Scholar 

  7. Anonymous. Strange english pigs. Lancet 294, 940–941 (1969).

  8. Benseler, V. et al. The liver: a special case in transplantation tolerance. Semin. Liver Dis. 27, 194–213 (2007).

    Article  CAS  PubMed  Google Scholar 

  9. Mazariegos, G.V. et al. Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. Transplant. Proc. 29, 1174–1177 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Starzl, T.E. et al. Cell migration, chimerism and graft acceptance. Lancet 339, 1579–1582 (1992).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Calne, R.Y. et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 314, 1033–1036 (1979).

    Article  Google Scholar 

  12. Calne, R.Y. & Williams, R. Liver transplantation in man. Observations on technique and organization in five cases. BMJ 4, 535–540 (1968).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Calne, R.Y. et al. Rapamycin for immunosuppression in organ allografting. Lancet 334, 227 (1989).

    Article  Google Scholar 

  14. Calne, R.Y. et al. H. Prope tolerance, perioperative campath IH, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 351, 1701–1702 (1998).

    Article  CAS  PubMed  Google Scholar 

  15. Calne, R.Y. & Watson, C.J.E. Some observations on prope tolerance. Curr. Opin. Organ Transplant. 16, 353–358 (2011).

    Article  CAS  PubMed  Google Scholar 

  16. Ringe, B. et al. Rescue of a living donor with liver transplantation. Am. J. Transplant. 8, 1557–1561 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Roy Y Calne.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calne, R. “It can't be done”. Nat Med 18, 1493–1495 (2012).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing